These are unique but exciting times, and while distance and physical separation are challenging, they cannot break the ties that bind our community together. We understand many are feeling isolated right now; however, the Cholangiocarcinoma Foundation (CCF) family is committed to moving forward.
We have seen significant progress in the basic, translational and clinical science. We have formed invaluable partnerships with corporations, industry and regulatory bodies, medical professionals and we have gained many new friends and family members. We have also said heartbreaking goodbyes. Through it all, we have continued to build, support, and drive progress together.
Together we can keep hope alive. We are building on the momentum that has been gained by the recent announcement of the first FDA approved targeted treatment for cholangiocarcinoma patients. This is the first of many exciting advancements coming down the pipeline. As CCF continues to collaborate, expand, and form new partnerships, we can expect continuing and increasing progress. Your donations are vital in helping us maintain this forward momentum.